You have 9 free searches left this month | for more free features.

Vemurafenib

Showing 1 - 25 of 186

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Colorectal Cancer Metastatic Trial (Tunlametinib plus Vemurafenib, Doublets Chemotherapy ± Bevacizumab or Doublets Chemotherapy

Not yet recruiting
  • Colorectal Cancer Metastatic
  • Tunlametinib plus Vemurafenib
  • Doublets Chemotherapy ± Bevacizumab or Doublets Chemotherapy ± Cetuximab
  • (no location specified)
Aug 15, 2023

Non-small-cell Lung Cancer Trial (HL-085+Vemurafenib)

Not yet recruiting
  • Non-small-cell Lung Cancer
  • (no location specified)
Jun 8, 2023

Hairy Cell Leukemia Trial in La Jolla (Low dose vemurafenib plus rituximab)

Recruiting
  • Hairy Cell Leukemia
  • Low dose vemurafenib plus rituximab
  • La Jolla, California
    Scripps MD Anderson Cancer Center
May 19, 2022

Melanoma Trial in Tampa (XL888, Vemurafenib)

Active, not recruiting
  • Melanoma
  • Tampa, Florida
    H. Lee Moffitt Cancer Center and Research Institute
Aug 18, 2022

Solid Tumors, Hematologic Cancers, Metastatic Cancers Trial in Paris (Vemurafenib)

Active, not recruiting
  • Solid Tumors
  • +2 more
  • Vemurafenib
  • Paris, France
    Tredaniel
May 18, 2022

Melanoma Trial in Ottawa, Toronto, Montreal (Vemurafenib, Cobimetinib)

Active, not recruiting
  • Melanoma
  • Ottawa, Ontario, Canada
  • +2 more
Oct 25, 2022

Histiocytosis Trial in Warsaw (Vemurafenib)

Recruiting
  • Histiocytosis
  • Vemurafenib
  • Warsaw, Mazovian, Poland
    Mother and Child Institute
Aug 2, 2022

Metastatic Melanoma Trial in Netherlands (drug, device, procedure)

Terminated
  • Metastatic Melanoma
  • Vemurafenib plus cobimetinib
  • +3 more
  • Amsterdam, Netherlands
  • +9 more
Nov 24, 2022

Melanoma Trial in Beijing (HL-085, Vemurafenib)

Recruiting
  • Melanoma
  • Beijing, Beijing, China
    Beijing Cancer Hospital
Apr 10, 2022

Thyroid Carcinoma Trial in New York (Vemurafenib, serial 124I PET/CT, thyrotropin alpha)

Active, not recruiting
  • Thyroid Carcinoma
  • Vemurafenib
  • +2 more
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Feb 28, 2022

Melanoma Trial in Napoli (Vemurafenib, Peg-interferon, Cobimetinib)

Completed
  • Melanoma
  • Vemurafenib
  • +2 more
  • Napoli, Italy
    Fondazione G.Pascale
Feb 23, 2022

Melanoma Trial in Pittsburgh (Pembrolizumab, Vemurafenib, Cobimetinib)

Terminated
  • Melanoma
  • Pittsburgh, Pennsylvania
    UPMC Cancer Center Hillman Cancer Center
Dec 10, 2021

BRAF NP_004324.2:p.V600X, KRAS wt Allele, Metastatic Malignant Solid Tumor Trial in Houston (biological, drug, other)

Active, not recruiting
  • BRAF NP_004324.2:p.V600X
  • +6 more
  • Cetuximab
  • +4 more
  • Houston, Texas
    M D Anderson Cancer Center
Sep 22, 2022

Histiocytosis Trial in Warsaw (Trametinib)

Recruiting
  • Histiocytosis
  • Warsaw, Mazovian, Poland
    Mother and Child Institute
Aug 2, 2022

Thyroid Cancer Trial in Houston (Vemurafenib (All Groups), Vemurafenib (Post Surgery) - Group A + C, Post Surgery - Group B)

Active, not recruiting
  • Thyroid Cancer
  • Vemurafenib (All Groups)
  • +2 more
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Nov 3, 2021

Melanoma Trial in Louisville (Vemurafenib, Metformin)

Recruiting
  • Melanoma
  • Louisville, Kentucky
    James Graham Brown Cancer Center-University of Louisville
Oct 22, 2021

Melanoma (Skin), Skin Cancer, Skin Melanoma Trial in Tampa (Vemurafenib, Cobimetinib)

Recruiting
  • Melanoma (Skin)
  • +3 more
  • Tampa, Florida
    H. Lee Moffitt Cancer Center and Research Institute
Dec 30, 2022

Solid Tumor Trial in Beijing, Zhengzhou, Hangzhou (HL-085, Vemurafenib)

Recruiting
  • Solid Tumor
  • Beijing, Beijing, China
  • +3 more
Jan 20, 2022

Pancreas Cancer Trial in Scottsdale (Vemurafenib, Sorafenib)

Recruiting
  • Pancreas Cancer
  • Scottsdale, Arizona
    HonorHealth Research Institute
Oct 28, 2021

Melanoma Trial in Italy (Cobimetinib 20 MG Oral Tablet, Vemurafenib 240 Mg Oral Capsule, Atezolizumab 1200 MG in 20 ML

Recruiting
  • Melanoma
  • Cobimetinib 20 MG Oral Tablet
  • +2 more
  • Bagno A Ripoli, Firenze, Italy
  • +5 more
Apr 12, 2022

Solid Tumor, Haematological Malignancy, Melanoma Trial in United Kingdom (Vemurafenib, Cobimetinib)

Recruiting
  • Solid Tumor
  • +11 more
  • Belfast, United Kingdom
  • +16 more
Mar 2, 2023

Pediatric Recurrent/Refractory BRAFV600E-mutant Gliomas Trial in Canada, United States (Vemurafenib)

Active, not recruiting
  • Pediatric Recurrent/Refractory BRAFV600E-mutant Gliomas
  • Vemurafenib
  • Los Angeles, California
  • +20 more
Jan 4, 2023

Colorectal Cancer Trial in Shanghai (Vemurafenib, Cetuximab)

Recruiting
  • Colorectal Cancer
  • Shanghai, Shanghai, China
    Shanghai Changzheng Hospital
Aug 15, 2021

CRC Trial in Beijing (HL-085, Vemurafenib)

Not yet recruiting
  • CRC
  • Beijing, Beijing, China
    Beijing Oncology Hospital
Feb 6, 2022

Thyroid Carcinoma, Thyroid Cancer, Thyroid Cancer, Follicular Trial in United States (I-124 PET/CT lesion dosimetry,

Recruiting
  • Thyroid Carcinoma
  • +5 more
  • I-124 PET/CT lesion dosimetry
  • +2 more
  • Basking Ridge, New Jersey
  • +6 more
Mar 3, 2022